AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St to open higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
RBC Capital upgrades Amgen (AMGN) on 'improving position of stability' and diminishing uncertainty
December 12, 2023 8:44 AM ESTRBC Capital lifted its rating for Amgen (NASDAQ: AMGN) to Outperform from Sector Perform in a note Tuesday, raising the price target to $300 from $256 per share.
Analyst Gregory Renza said the company's pipeline optionality, as well as its 2024 catalyst setup, positions it... More
